CHICAGO (Reuters) - After years of uncertainty, a nearly decade-long study showed that Merck & Co's cholesterol drug Zetia lowered the risk of heart attacks and strokes in high-risk heart patients ...
A new study casts some doubt on the benefits of Zetia, a cholesterol-lowering drug that about 1 million people in the U.S. use. The "Enhance" trial studied a combination of Zetia and the statin drug ...
ORLANDO, Fla., Nov 16 (Reuters) - The good news for Merck & Co's Zetia cholesterol fighter is that doctors do not seem unduly concerned about its latest setback in a clinical trial. The bad news is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback